Gene · 6443
Papers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,640
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MKP-1 Deficiency Exacerbates Skin Fibrosis in a Mouse Model of Scleroderma. | Int J Mol Sci | 2023 | 36902103 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure. | Int J Mol Sci | 2023 | 36901752 | PubTator, text mining | PubMed |
| Tongmai Yangxin pill alleviates myocardial no-reflow by activating GPER to regulate HIF-1α signaling and downstream potassium channels. | Pharm Biol | 2023 | 36896463 | PubTator, text mining | PubMed |
| The ratio of TAPSE to PASP predicts prognosis in lung transplant candidates with pulmonary arterial hypertension. | Sci Rep | 2023 | 36882461 | PubTator, text mining | PubMed |
BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex. | Mol Pharmacol | 2023 | 36868790 | PubTator, text mining | PubMed |
| Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis. | Front Pharmacol | 2023 | 36865908 | PubTator, text mining | PubMed |
| Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents. | RSC Adv | 2023 | 36865574 | PubTator, text mining | PubMed |
| High-throughput screening for myelination promoting compounds using human stem cell-derived oligodendrocyte progenitor cells. | iScience | 2023 | 36852281 | PubTator, text mining | PubMed |
| Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension. | Int J Mol Sci | 2023 | 36835383 | PubTator, text mining | PubMed |
| The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. | Cancers (Basel) | 2023 | 36831561 | PubTator, text mining | PubMed |
| Bioactive Formulations in Agri-Food-Pharma: Source and Applications. | Bioengineering (Basel) | 2023 | 36829685 | PubTator, text mining | PubMed |
| The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies. | Aging Dis | 2023 | 36818566 | PubTator, text mining | PubMed |
| Systemic γ-sarcoglycan AAV gene transfer results in dose-dependent correction of muscle deficits in the LGMD 2C/R5 mouse model. | Mol Ther Methods Clin Dev | 2023 | 36816759 | PubTator, text mining | PubMed |
| Variants in DTNA cause a mild, dominantly inherited muscular dystrophy. | Acta Neuropathol | 2023 | 36799992 | PubTator, text mining | PubMed |
| Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity. | Pulm Circ | 2023 | 36788941 | PubTator, text mining | PubMed |
| Epidemiology and Clinical Burden of Meningococcal Disease in France: Scoping Review. | J Clin Med | 2023 | 36769498 | PubTator, text mining | PubMed |
| UHPLC-MS Phenolic Fingerprinting, Aorta Endothelium Relaxation Effect, Antioxidant, and Enzyme Inhibition Activities of Azara dentata Ruiz & Pav Berries. | Foods | 2023 | 36766170 | PubTator, text mining | PubMed |
| Integrative competing endogenous RNA network analyses identify novel lncRNA and genes implicated in metastatic breast cancer. | Sci Rep | 2023 | 36765262 | PubTator, text mining | PubMed |
| The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure. | J Cardiovasc Aging | 2023 | 36742465 | PubTator, text mining | PubMed |
| Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease. | J Am Heart Assoc | 2023 | 36734336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6443/papers?page=14